about
Immunotherapy as treatment for Alzheimer’s diseaseImmunotherapeutic approaches for Alzheimer's diseaseThe serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's diseasePreventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors.Novel immunological approaches for the treatment of Alzheimer's disease.Neuronal death in Alzheimer's disease and therapeutic opportunities.Therapeutic approaches for prion and Alzheimer's diseases.Neuregulin-1 (Nrg1) signaling has a preventive role and is altered in the frontal cortex under the pathological conditions of Alzheimer's diseaseAmyloid-beta immunisation for Alzheimer's diseaseAD vaccines: conclusions and future directions.Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.Vaccination as a therapeutic approach to Alzheimer's disease.Murine models of Alzheimer's disease and their use in developing immunotherapies.Developing therapeutic vaccines against Alzheimer's disease.Disease-modifying anti-Alzheimer's drugs: inhibitors of human cholinesterases interfering with β-amyloid aggregation.Multifunctional cholinesterase and amyloid Beta fibrillization modulators. Synthesis and biological investigation.Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging.Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1-42 Aggregation Inhibitors for Alzheimer's Disease Therapy.
P2860
Q22241491-F47C97A1-5E31-403E-8A17-239ABDF273EAQ28081278-F7D4FF4B-DECB-47DA-A34B-0F15C8B7EFF3Q28251394-DB06B447-B75B-4637-87C7-ABB0C29DF3D9Q30855109-ACFD9ADA-DEE6-4E8F-BC69-148E91F89A3AQ34562675-256D04D7-DCDE-48FD-AE72-062B625F9DEFQ35889067-9F52782A-A93F-4D3C-AA67-5C3BDA6476A4Q36872884-F1692975-491D-4C44-A943-953469BA413AQ37190917-EA2B1A9F-3EF1-428C-AEA1-F627E9BD0346Q37230661-3CD652E3-A955-40AA-9054-537129163D8AQ37438273-EBD5A3DB-7979-482C-B361-6475A9931C44Q37655247-B95DD6CD-DE2A-43A3-A379-8FDEAA1EEDEBQ37681432-CA80A9D2-AAA0-4757-8986-9FC842C4CFA4Q37752915-C4DBB995-EF7A-46C4-81A3-53ACE883B7A6Q38636151-42D92A0D-1C67-4282-85E5-7917A30792BDQ38984017-03550983-B3AC-4BC5-BA9A-4A7398ECAFF6Q39778610-08E2F476-278B-4077-B1D5-F1071301272DQ43074512-8BCBCE72-54B8-433F-979E-9B0D375F82DCQ53372587-CD48E4CB-A609-4567-BFA5-B96DE38CD802
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Disease modifying approaches for Alzheimer's pathology.
@en
type
label
Disease modifying approaches for Alzheimer's pathology.
@en
prefLabel
Disease modifying approaches for Alzheimer's pathology.
@en
P1476
Disease modifying approaches for Alzheimer's pathology
@en
P2093
Marcin Sadowski
Thomas Wisniewski
P304
P356
10.2174/138161207781039788
P577
2007-01-01T00:00:00Z